Last data update: Jun 08, 2023 . (Total: 45401 Documents since 2020)
Records 1-7 (of 7 Records)
|Query Trace: All of us research[original query]|
| Design and Implementation of the All of Us Research Program COVID-19 Participant Experience (COPE) Survey.
Claire E Schulkey et al. American journal of epidemiology 2023 2
In response to the rapidly evolving COVID-19 pandemic, the All of Us Research Program longitudinal cohort study developed the COVID-19 Participant Experience (COPE) survey to better understand the pandemic experiences and health impacts of COVID-19 on diverse populations within the United States. Six survey versions were deployed between May 2020 and March 2021 covering mental health, loneliness, activity, substance use, and discrimination, as well as COVID-19 symptoms, testing, treatment, and vaccination. A total of 104,910 All of Us Research Program participants, of whom over 73% were from communities traditionally underrepresented in biomedical research, completed 275,201 surveys; 9,693 completed all six surveys
| The Impact of COVID-19 on the All of Us Research Program.
Hedden Sarra L et al. American journal of epidemiology 2022 10
Before the pandemic, the program was enrolling approximately 12,500 participants per month at more than 400 clinic sites. In March 2020, all in-person activity at sites and by engagement partners was paused to develop processes and procedures for in-person activities that incorporate strict safety protocols because of the pandemic. In addition, the program adopted new data collection methodologies to reduce the need for in-person activities. Through February 2022, 224 clinic sites have reactivated in-person activity, and all enrollment and engagement partners have adopted new data collection methodologies that can be completed remotely.
| Colliding with Collider Bias: Implications for Precision Public Health
D Rasooly et al, CDC Blog Post, May 9, 2022
Large-scale genomic studies have uncovered thousands of statistical associations between genetic variants and health outcomes, transforming our understanding of the genetic determinants of human diseases. Nevertheless, study sample selection and attrition over time can bias associations between variables, generating potentially biased estimates for genetic associations. This bias can be magnified in the case of studying phenotypic associations with polygenic risk scores in large scale cohort studies of unrepresentative or highly selected populations, such as the UK biobank, and potentially in the newly launched All of Us Research Program cohort study.
| Built environment’s impact on COVID-19 transmission and mental health revealed by COVID-19 Participant Experience data from the All of Us Research Program
W Luo et al, MEDRXIV, April 8, 2022
| Household transmission of SARS-CoV-2 Alpha variant - United States, 2021.
Donnelly Marisa A P, et al. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2022 0 0.
| Antibodies to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in All of Us Research Program Participants, 2 January to 18 March 2020.
Althoff Keri N et al. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2021 74(4) 584-590
| NIH study offers new evidence of early SARS-CoV-2 infections in U.S.
NIH, June 15, 2021
A new antibody testing study examining samples originally collected through the National Institutes of Health?s All of Us Research Program found evidence of SARS-CoV-2 infections in five states earlier than had initially been reported. These findings were published in the journal Clinical Infectious Diseases. The results expand on findings from a Centers for Disease Control and Prevention study that suggested SARS-CoV-2, the virus that causes COVID-19, was present in the U.S. as far back as December 2019.
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2023
- Page last updated:Jun 08, 2023
- Content source: